Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1117 of 6351
-
Second radiation course shows promise for returning brain tumors in kids
Disease control OngoingThe primary purpose of this study is to investigate whether surgery and re-irradiation will help treat ependymoma that has come back after initial treatment. The combined doses of the first and second courses of radiation are higher than what is usual standard of care. The invest…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
A new drug combo may shield kidney transplant patients from a common viral threat
Disease control CompletedCytomegalovirus (CMV) infection is the most frequent opportunistic viral infection after transplantation. It is associated with an increased incidence of acute rejection and lower graft and patient survivals. The goal of this study is to demonstrate that an immunosuppressive regi…
Phase 4 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Brainstem implant offers hope for children born without hearing nerves
Disease control Recruiting nowThis study is a feasibility study of the Nucleus 24 ABI in children without NF2. It will be conducted as a repeated-measures, single subject experiment in order to accommodate the known variability in cochlear implant clinical results. Data obtained in the course of this study wi…
Sponsor: NYU Langone Health • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New combo therapy aims to keep lymphoma in check longer
Disease control OngoingA randomized phase III multicenter trial assessing efficacy and toxicity of a combination of Rituximab and Lenalidomide (R2) vs Rituximab alone as maintenance after chemoimmunotherapy with Rituximab-chemotherapy (R-CHT) for relapsed/refractory FL patients not eligible for autolog…
Phase 3 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
A tiny molecule may shield sperm DNA from freezing damage
Disease control CompletedAlthough it is widely used, slow freezing can induce strong functional and nuclear spermatic alterations reducing the chances of pregnancy. The study objective is to determinate the effects of the combination of hypotaurine supplementation and spermatozoa selection by Density Gra…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Measles virus hijacks stem cells to attack ovarian cancer
Disease control OngoingThis phase I/II trial studies the side effects and best dose of oncolytic measles virus encoding thyroidal sodium iodide symporter (MV-NIS) infected mesenchymal stem cells and to see how well it works in treating patients with ovarian, primary peritoneal or fallopian tube cancer …
Phase 1/2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New hope for prostate cancer: enzalutamide slows progression in asian men
Disease control CompletedPurpose of the study was to assess the effect of enzalutamide on time to Prostate Specific Antigen (PSA) progression as compared to placebo in chemotherapy naïve participants with progressive metastatic prostate cancer who have failed androgen deprivation therapy.
Phase 3 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Could a special mesh stop hernias after colostomy?
Prevention CompletedIn France around 5,000 colostomies are performed after elective or emergency surgery. These colostomies could be associated with major outcomes including parastomal hernia (4 - 53%) of cases. To reduce the incidence of these outcomes, several methods have been proposed but the m…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Prevention
Last updated Jun 27, 2026 13:07 UTC
-
New hope for relapsed myeloma: Triple-Drug cocktail under study
Disease control CompletedImnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide (Revlimid) and bortezomib (Velcade), and have demonstrated …
Phase 2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can a new device prevent aortic aneurysm rupture?
Disease control CompletedThe study purpose is to determine the safety and efficacy of the BMFM used for the endovascular treatment of aortic aneurysm involving iliac arteries. The BMFM is an adaptation of the aortic MFM® to the aorto-iliac bifurcation anatomy. It should be noted that the aortic MFM® has …
Sponsor: Cardiatis • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for recurrent ovarian cancer: targeted drug may slow tumor growth
Disease control CompletedThis phase II/III trial studies how well trametinib works and compares it to standard treatment with either letrozole, tamoxifen, paclitaxel, pegylated liposomal doxorubicin, or topotecan in treating patients with low-grade ovarian cancer or peritoneal cavity cancer that has come…
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
A simple blood test may reveal hidden infertility risk in young cancer survivors
Knowledge-focused Recruiting nowWhile most of the children spontaneously recover menstruation or experienced normal puberty after chemotherapy, their ovarian reserve may be impaired by treatment inducing future infertility. Fertility preservation is currently proposed for selected prepubertal patients with a hi…
Sponsor: Erasme University Hospital • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
New hope for fanconi anemia: safer stem cell transplant trial opens
Disease control Recruiting nowThe purpose of this study is to determine whether the use of lower doses of busulfan and the elimination of cyclosporine will further reduce transplant-related side effects for patients with Fanconi Anemia (FA). Patients will undergo a transplant utilizing mis-matched related or …
Phase 2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Donor immune cells show promise against returning blood cancers
Disease control OngoingPatients have a type of lymph gland cancer called Non-Hodgkin Lymphoma (NHL), acute lymphocytic leukemia (ALL) or chronic lymphocytic leukemia (CLL) (these diseases will be referred to as "lymphoma" or "leukemia"). The lymphoma or leukemia has come back or has not gone away after…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Custom-Made melanoma vaccine shows promise in early trial
Vaccine CompletedThis research study is evaluating a new type of melanoma vaccine called "Personalized NeoAntigen Cancer Vaccine". The purpose of this study is to determine if it is possible to make and administer safely a vaccine against melanoma by using information gained from specific charact…
Phase 1 • Sponsor: Patrick Ott, MD, PhD • Aim: Vaccine
Last updated Jun 27, 2026 08:07 UTC
-
Engineered immune cells plus chickenpox vaccine take on childhood cancers
Disease control OngoingThe purpose of this study is to find the largest safe dose of GD2-T cells (also called iC9-GD2-CAR-VZV-CTLs) in combination with a varicella zoster vaccine and lymohodepleting chemotherapy. Additionally, we will learn what the side effects of this treatment are and to see whether…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Promising combo therapy offers hope for kids with hard-to-treat brain cancers
Disease control Recruiting nowPatients with with recurrent or progressive medulloblastoma, ependymoma, atypical teratoid rhabdoid tumor (ATRT), and CNS tumors of various histologies have a very poor prognosis whether treated with conventional chemotherapy, high-dose chemotherapy with stem cell rescue, irradia…
Phase 2 • Sponsor: Medical University of Vienna • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Can mapping tumor DNA unlock personalized breast cancer care?
Knowledge-focused Recruiting nowThis program initially aims to recruit 1300 breast cancer patients from a large number of hospitals across Europe. Eligible patients are those who are 18 or older, either female or male, and who have not received more than 1 type of treatment from the time metastases were discove…
Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Double-Dose chemo strategy shows promise against pancreatic cancer
Disease control CompletedThis phase II trial studies how well combination chemotherapy before and after surgery works in treating patients with localized pancreatic cancer. Drugs used in chemotherapy, such as leucovorin calcium, fluorouracil, irinotecan hydrochloride, and oxaliplatin, work in different w…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Triple drug cocktail takes on tough melanoma
Disease control OngoingThis phase I/II trial studies the side effects and best dose of dabrafenib, trametinib, and navitoclax and to see how well they work in treating patients with BRAF mutant melanoma or solid tumors that has spread from where it first started (primary site) to other places in the bo…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC